RU2003131099A - COMPOSITION FOR TREATMENT OF ACUTE RESPIRATORY DISEASES OF HIB-ETIOLOGY IN CHILDREN AND METHOD OF TREATMENT - Google Patents

COMPOSITION FOR TREATMENT OF ACUTE RESPIRATORY DISEASES OF HIB-ETIOLOGY IN CHILDREN AND METHOD OF TREATMENT Download PDF

Info

Publication number
RU2003131099A
RU2003131099A RU2003131099/15A RU2003131099A RU2003131099A RU 2003131099 A RU2003131099 A RU 2003131099A RU 2003131099/15 A RU2003131099/15 A RU 2003131099/15A RU 2003131099 A RU2003131099 A RU 2003131099A RU 2003131099 A RU2003131099 A RU 2003131099A
Authority
RU
Russia
Prior art keywords
treatment
respiratory diseases
acute respiratory
children
dose
Prior art date
Application number
RU2003131099/15A
Other languages
Russian (ru)
Other versions
RU2258524C2 (en
Inventor
Сергей Георгиевич Горбунов (RU)
Сергей Георгиевич Горбунов
Тамара Васильевна Мацулевич (RU)
Тамара Васильевна Мацулевич
Игорь Измаилович Вайншток (RU)
Игорь Измаилович Вайншток
Original Assignee
Закрытое акционерное общество "Партнер" (RU)
Закрытое акционерное общество "Партнер"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Закрытое акционерное общество "Партнер" (RU), Закрытое акционерное общество "Партнер" filed Critical Закрытое акционерное общество "Партнер" (RU)
Priority to RU2003131099/15A priority Critical patent/RU2258524C2/en
Publication of RU2003131099A publication Critical patent/RU2003131099A/en
Application granted granted Critical
Publication of RU2258524C2 publication Critical patent/RU2258524C2/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Claims (3)

1. Лечебно-профилактическая композиция для лечения острых респираторных заболеваний у детей, содержащая лиофилизированную микробную массу живых бифидобактерий, адсорбированных на частицах активированного угля и лактозу, отличающаяся тем, что она дополнительно содержит микробную массу живых лактобактерий при следующем соотношении компонентов на одну терапевтическую дозу, г:1. Therapeutic and prophylactic composition for the treatment of acute respiratory diseases in children, containing a lyophilized microbial mass of live bifidobacteria adsorbed on activated carbon particles and lactose, characterized in that it additionally contains a microbial mass of live lactobacilli in the following ratio of components per therapeutic dose, g : Бифидобактерий 5×105-5×108 КОЕBifidobacteria 5 × 10 5 -5 × 10 8 CFU Лактобактерий 5×105-5×108 КОЕLactobacillus 5 × 10 5 -5 × 10 8 CFU Активированный уголь 0,00001-0,0001Activated Carbon 0.00001-0.0001 Лактоза 0,59-1,0Lactose 0.59-1.0 2. Лечебно-профилактическая композиция по п.1, отличающаяся тем, что она выполнена в виде герметичного пакетика массой 0,6-1,1 г.2. The treatment and prophylactic composition according to claim 1, characterized in that it is made in the form of an airtight sachet weighing 0.6-1.1 g. 3. Способ лечения острых респираторных заболеваний, включающий комплексную терапию с использованием пробиотического препарата, отличающийся тем, что принимают лечебно-профилактическую композицию по п.1, в дозе 0,6-1,1 г 3 раза в день перорально независимо от приема пищи, предварительно разведя указанную дозу в 30-50 мл жидкости комнатной температуры, в течение 3-10 дней.3. A method for the treatment of acute respiratory diseases, comprising complex therapy using a probiotic preparation, characterized in that the treatment and prophylactic composition according to claim 1 is taken, at a dose of 0.6-1.1 g 3 times a day, orally, regardless of food intake, after diluting the specified dose in 30-50 ml of a liquid at room temperature, for 3-10 days.
RU2003131099/15A 2003-10-23 2003-10-23 Composition for treatment of acute respiratory diseases of hib-etiology in children and method for treatment RU2258524C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2003131099/15A RU2258524C2 (en) 2003-10-23 2003-10-23 Composition for treatment of acute respiratory diseases of hib-etiology in children and method for treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2003131099/15A RU2258524C2 (en) 2003-10-23 2003-10-23 Composition for treatment of acute respiratory diseases of hib-etiology in children and method for treatment

Publications (2)

Publication Number Publication Date
RU2003131099A true RU2003131099A (en) 2005-04-10
RU2258524C2 RU2258524C2 (en) 2005-08-20

Family

ID=35611502

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003131099/15A RU2258524C2 (en) 2003-10-23 2003-10-23 Composition for treatment of acute respiratory diseases of hib-etiology in children and method for treatment

Country Status (1)

Country Link
RU (1) RU2258524C2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008053444A2 (en) * 2006-11-01 2008-05-08 The Procter & Gamble Company Treating a respiratory condition with bifidobacterium
EP2455092A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect against upper respiratory tract infections

Also Published As

Publication number Publication date
RU2258524C2 (en) 2005-08-20

Similar Documents

Publication Publication Date Title
EP2708599B1 (en) Lactobacillus plantarum able to relieve lead toxicity and use thereof
Yasui et al. Immunomodulatory function of lactic acid bacteria
JP2004524836A5 (en)
RU2005104950A (en) Probiotics for the neuromuscular function of the intestine
JP2005506063A5 (en)
RU2003125858A (en) PROBIOTIC COMBINATION
CN107821896A (en) A kind of live body compound probiotic drink
CN114848685B (en) Antiallergic probiotic composition, application thereof and probiotic traditional Chinese medicine fermentation product
Araújo et al. Probiotics in dairy fermented products
KR102606952B1 (en) Method of Lactobacillus Plantarum TWK10 composition for improving inflammation or reducing body fat after exercise
JP4913986B2 (en) Solid composition containing spores of non-pathogenic bacteria of the genus Bacillus
Hur et al. Production of nitric oxide, tumor necrosis factor-α and interleukin-6 by RAW264. 7 macrophage cells treated with lactic acid bacteria isolated from kimchi
RU2005117356A (en) METHOD FOR SUPPRESSING YEAST GROWTH
JP2005013211A (en) Lactobacillus-containing food composition
RU2003131099A (en) COMPOSITION FOR TREATMENT OF ACUTE RESPIRATORY DISEASES OF HIB-ETIOLOGY IN CHILDREN AND METHOD OF TREATMENT
CN108936607A (en) Chronic Obstructive Pulmonary Disease full nutrition formula food
HoSoNo et al. Impact of fermented milk on human health: cholesterol‐lowering and immunomodulatory properties of fermented milk
Hur et al. In vitro immunopotentiating activities of cellular fractions of lactic acid bacteria isolated from kimchi and bifidobacteria
JP2009155221A (en) Interleukin 12 production promoter
RU2164801C1 (en) Preparation-probiotic as dry immobilized form
CN1799634A (en) Antivirus air humidifying agent for living rooms
RU2371479C1 (en) Complex probiotic medicine in immobilised and lyophilised form
Di Cerbo et al. The use of probiotics in the end-stage renal disease management
CN110075207A (en) Community resident's flu prevention sachet and its Chinese medicine composition
CN108504610A (en) The enriched medium of clostridium butyricum, the preparation method of enrichment method, freezing drying protective agent and its freeze-dried powder

Legal Events

Date Code Title Description
PD4A Correction of name of patent owner
PC41 Official registration of the transfer of exclusive right

Effective date: 20190131

PC41 Official registration of the transfer of exclusive right

Effective date: 20190226